Advertisement

COVID-19: Govt panel recommends emergency use authorisation for Corbevax vaccine for 5-11 age group

Biological E's Corbevax is currently being used to inoculate children aged 12-14 years. It is India's first protein sub-unit COVID vaccine

Advertisement
|Apr 21, 2022, 22:24:21 IST

New Delhi: An expert panel of India's central drug authority has recommended granting emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for children in the five to 11 years age group, official sources said on Thursday.

The Subject Expert Committee on COVID-19 of the CDSCO has, however, sought more data from Bharat Biotech to review its emergency use authorisation (EUA) application for use of Covaxin among those aged between two and 11 years, they said.

Advertisement

The Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on 28 December last year and in the 12 to 17 years age group, subject to certain conditions, on 9 March this year.

Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years. Covaxin has been granted Emergency Use Listing (EUL) by the DCGI for the age group of 12 to 18 years on 24 December, 2021.

healthMore from Health

"The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological E's EUA application has recommended granting emergency use authorisation for use of Corbevax in the age group of five to 11 years," a source said.

India began inoculating children aged 12-14 on 16 March.

The countrywide vaccination drive was rolled out on 16 January last year with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from 2 February last year.

Advertisement

The next phase of COVID-19 vaccination commenced on 1 March last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.

India launched vaccination for all people aged more than 45 years from 1 April last year. The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from 1 May last year.

The next phase of vaccination commenced on 3 January for adolescents in the age group of 15-18 years.

India began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from 10 January.

Precaution does of COVID-19 vaccines to all aged above 18 years was allowed at private vaccination centres from 10 April.

Read all the Latest News, Trending NewsCricket News, Bollywood News,

India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.

Advertisement
Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Apr 21, 2022, 21:20:48 IST
Advertisement
Advertisement
Trending Stories

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.
5 min read
Advertisement
Advertisement
Up Next